Treatments associated with lower mortality among critically ill COVID-19 patients: a retrospective cohort study

X Zhao, C Gao, F Dai, MM Treggiari, R Deshpande… - …, 2021 - pubs.asahq.org
Background Mortality in critically ill COVID-19 patients remains high. Although randomized
controlled trials must continue to definitively evaluate treatments, further hypothesis …

Factors associated with mortality in patients with COVID‐19 admitted to intensive care: a systematic review and meta‐analysis

EH Taylor, EJ Marson, M Elhadi, KDM Macleod… - …, 2021 - Wiley Online Library
Identification of high‐risk patients admitted to intensive care with COVID‐19 may inform
management strategies. The objective of this meta‐analysis was to determine factors …

Mortality in patients admitted to intensive care with COVID‐19: an updated systematic review and meta‐analysis of observational studies

RA Armstrong, AD Kane, E Kursumovic… - …, 2021 - Wiley Online Library
The COVID‐19 pandemic continues to cause critical illness and deaths internationally. Up to
31 May 2020, mortality in patients admitted to intensive care units (ICU) with COVID‐19 was …

[HTML][HTML] Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID‐19: a multi‐center, open‐label, randomized controlled trial

US Perepu, I Chambers, A Wahab, P Ten Eyck… - Journal of thrombosis …, 2021 - Elsevier
Abstract Background Coronavirus disease 2019 (COVID‐19) is associated with
coagulopathy but the optimal prophylactic anticoagulation therapy remains uncertain and …

Outcomes from intensive care in patients with COVID‐19: a systematic review and meta‐analysis of observational studies

RA Armstrong, AD Kane, TM Cook - Anaesthesia, 2020 - Wiley Online Library
The emergence of coronavirus disease 2019 (COVID‐19) has led to high demand for
intensive care services worldwide. However, the mortality of patients admitted to the …

Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study

K Al Sulaiman, O Aljuhani, GB Korayem, A Hafiz… - Thrombosis …, 2022 - Springer
Background Thrombotic events are common in critically ill patients with COVID-19 and have
been linked with COVID-19-induced hyperinflammatory state. In addition to anticoagulant …

Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)

ACB Lemos, DA do Espírito Santo, MC Salvetti… - Thrombosis research, 2020 - Elsevier
Abstract Introduction Coronavirus disease 2019 (COVID-19) causes a hypercoagulable
state. Several autopsy studies have found microthrombi in pulmonary circulation. Methods In …

Empiric use of anticoagulation in hospitalized patients with COVID-19: a propensity score-matched study of risks and benefits

B Yu, VP Gutierrez, A Carlos, G Hoge, A Pillai… - Biomarker …, 2021 - Springer
Background Hospitalized patients with COVID-19 demonstrate a higher risk of developing
thromboembolism. Anticoagulation (AC) has been proposed for high-risk patients, even …

Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials

MA Wu, C Del GIovane, R Colombo, G Dolci… - Internal and emergency …, 2024 - Springer
Abstract Coronavirus disease 2019 (COVID-19) carries a high risk of vascular thrombosis.
However, whether a specific anticoagulation intensity strategy may prevent clinical …

National outcomes and characteristics of patients admitted to Swedish intensive care units for COVID-19: a registry-based cohort study

MS Chew, PJ Blixt, R Åhman… - European Journal of …, 2021 - journals.lww.com
BACKGROUND Mortality among patients admitted to intensive care units (ICUs) with COVID-
19 is unclear due to variable follow-up periods. Few nationwide data are available to …